Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) Profit Margin

As of the most recent data (June 2026), SRNGU shows a profit margin of -314.76%. That compares with -136.56% in the prior-year period — down 130.5% year over year. That is below the Healthcare sector average of 14.41%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SRNGU's profit margin is now -314.76% (was -136.56%) — a 130.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) is outperforming or lagging.

The Healthcare sector average profit margin is about 14.41%. Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) is at -314.76%, which is lower that average. That is roughly 2283.6% below the sector mean. Use the comparison chart on this page to see how SRNGU stacks up against individual peers as well.

That compares with -136.56% in the prior-year period — down 130.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -314.76%) with ownership activity and broader fundamentals.